Blog posts

Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of ColoAlert in Europe and the United Arab Emirates (UAE)

May 19, 2022

Dante Labs is a Global Leader in Genomics and Precision Medicine Mainz is Exclusively Focused on Developing Next Generation Diagnostics for the Early Detection of Cancer BERKELEY, Calif....

Dante Labs receives grant by Italian government to pilot revolutionary CE-IVD, clinical whole genome sequencing-based Citizen Test for a G7 country, starting a new era in clinical genomics

May 10, 2022

NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, is pleased to announce the Italian Ministry of Economic Development has selected Dante to...

What is Hereditary Cancer?

May 9, 2022

Cancer is, unfortunately, an exceptionally common disease. Most of us have known someone in our families or friendship circles that have experienced it. Cancer occurs when cells mutate and grow...

What is a Genetic Disorder?

May 3, 2022

An exploration of genetic disorders: why do they occur and when is it necessary to seek out testing and treatment? The human genome is a complex set of instructions that...

What's in a Health Report?

May 3, 2022

Learn how at risk you are from developing health conditions and disease with a whole genome sequencing test from Dante. About Hereditary DiseasesThe future of our health lies deep...

Dr. Yendry Ventura Carmenate, General Manager at Abu Dhabi Stem Cells Center and Carlo Logli, Chief Global Affairs Officer at Dante Labs, signed the agreement at the ADSCC premises in Abu Dhabi.

Dante Labs selected to provide genetic testing for Abu Dhabi Stem Cells Center, jointly developing mRNA cancer vaccines

April 28, 2022

NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, is pleased to announce the company has been selected as the genetic...

Item added to your cart